This opportunity is no longer accepting applications.
grant PAR-21-290

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

The National Cancer Institute is offering grants for research projects that aim to use imaging and liquid biopsy tests to monitor cancer during treatment. The goal is to find the best ways to use these methods to understand how well patients are responding to therapy and if resistance to the treatment is developing.

Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal u…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Awards & funding

Award Ceiling: $500,000
Award Amount: $500,000

Dates

Opportunity Released: July 22, 2021
Open for Submission: July 22, 2021
Submission Deadline: September 7, 2024
Application Window Closes: September 7, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.